Greg Pond, PhD
Ontario Clinical Oncology Group (OCOG)
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mark Levine, MD
Ontario Clinical Oncology Group (OCOG)
Shared therapeutic areas:
Worked with same sponsors:
Sebastien Hotte, MD
Juravinski Cancer Centre
Shared therapeutic areas:
Worked with same sponsors:
Susumu Okano, MD, PhD
National Cancer Center Hospital East
Shared therapeutic areas:
Glenn J. Hanna, M.D
Dana-Farber Cancer Institute
Shared therapeutic areas:
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Mark Kowalski, MD
Tekmira Pharmaceuticals
Shared therapeutic areas:
Tianhong Li, MD
University of California, Davis
Shared therapeutic areas:
Yan Sun, Doctor
Peking Univesity, Beijing Cancer Hospital
Shared therapeutic areas:
Shalini Makawita, MD
Baylor College of Medicine
Shared therapeutic areas:
Jianguo Zhang, Doctor
Peking University, School of Stomatolgy
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
All 1 trials loaded